Apogenix Overview
- Year Founded
-
2005
- Status
-
Out of Business
- Employees
-
30
- Latest Deal Type
-
Liquidation
Apogenix General Information
Description
Developer of immuno-oncology therapeutics designed to treat cancer and other malignant diseases. The company's platform targets critical pathways involved in the proliferation, migration, and apoptosis of diseased cells, boosting the immune response cycle to strengthen and prolong the anti-tumor immune response, enabling patients to develop anti-tumor immune cells that can fight back if a tumor reoccurs.
Contact Information
Website
www.apogenix.comCorporate Office
- Im Neuenheimer Feld 584
- 69120 Heidelberg
- Germany
Corporate Office
- Im Neuenheimer Feld 584
- 69120 Heidelberg
- Germany
Apogenix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Bankruptcy: Liquidation | 31-Dec-2025 | Completed | Bankruptcy: Liquidation | |||
| 9. Later Stage VC | 09-Dec-2021 | Completed | Clinical Trials - Phase 2 | |||
| 8. Grant | 16-Feb-2016 | Completed | Clinical Trials - Phase 2 | |||
| 7. Later Stage VC (Series C) | 05-Jan-2012 | Completed | Clinical Trials - Phase 2 | |||
| 6. Grant | 03-Jan-2012 | Completed | Clinical Trials - Phase 2 | |||
| 5. Grant | 29-Jul-2009 | Completed | Startup | |||
| 4. Grant | 19-Sep-2008 | Completed | Startup | |||
| 3. Early Stage VC (Series B) | 30-Apr-2008 | Completed | Startup | |||
| 2. Grant | 12-Mar-2007 | $1.97M | Completed | Startup | ||
| 1. Early Stage VC | 01-Nov-2005 | Completed | Startup |
Apogenix Comparisons
Industry
Financing
Details
Apogenix Competitors (35)
One of Apogenix’s 35 competitors is Artios, a Venture Capital-Backed company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Artios | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Gylden Pharma | Venture Capital-Backed | Abingdon, United Kingdom | ||||
| Verseau Therapeutics | Venture Capital-Backed | Auburndale, MA | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| Iovance Biotherapeutics | Corporation | San Carlos, CA |
Apogenix Patents
Apogenix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023088889-A1 | Cd137 ligands | Inactive | 16-Nov-2021 | ||
| WO-2023088876-A1 | Multi-specific immune modulators | Inactive | 16-Nov-2021 | ||
| EP-4149964-A2 | Multi-specific immune modulators | Inactive | 15-May-2020 | ||
| US-20230212260-A1 | Multi-specific immune modulators | Inactive | 15-May-2020 | ||
| WO-2021229103-A2 | Multi-specific immune modulators | Inactive | 15-May-2020 | C07K14/70575 |
Apogenix Signals
Apogenix FAQs
-
When was Apogenix founded?
Apogenix was founded in 2005.
-
Where is Apogenix headquartered?
Apogenix is headquartered in Heidelberg, Germany.
-
What is the size of Apogenix?
Apogenix has 30 total employees.
-
What industry is Apogenix in?
Apogenix’s primary industry is Drug Discovery.
-
Is Apogenix a private or public company?
Apogenix is a Private company.
-
What is Apogenix’s current revenue?
The current revenue for Apogenix is .
-
How much funding has Apogenix raised over time?
Apogenix has raised $76.5M.
-
Who are Apogenix’s competitors?
Artios, Gylden Pharma, Verseau Therapeutics, Kite Pharma, and Iovance Biotherapeutics are some of the 35 competitors of Apogenix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process